Partial p53 reactivation is sufficient to induce cancer regression.
Boris KlimovichLaura MeyerNastasja MerleMichelle NeumannAlexander M KönigNikolaos AnanikidisCorinna U KeberSabrina ElmshäuserOleg TimofeevThorsten StiewePublished in: Journal of experimental & clinical cancer research : CR (2022)
The observation that a partial loss-of-function p53 variant promotes tumorigenesis in one setting and induces regression in another, underlines the highly context-specific effects of individual p53 mutants. It further highlights the exquisite sensitivity of cancer cells to even small changes in p53 activity and reveals that changes in activity level are more important than the absolute level. As such, the study encourages ongoing research efforts into mutant p53 reactivating drugs by providing genetic proof-of-principle evidence that incomplete p53 reactivation may suffice to elicit a therapeutic response.